15-48791380-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001194998.2(CEP152):​c.833-4G>A variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.438 in 1,607,084 control chromosomes in the GnomAD database, including 157,597 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.40 ( 12474 hom., cov: 31)
Exomes 𝑓: 0.44 ( 145123 hom. )

Consequence

CEP152
NM_001194998.2 splice_region, intron

Scores

2
Splicing: ADA: 0.00002314
2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: -0.136

Publications

11 publications found
Variant links:
Genes affected
CEP152 (HGNC:29298): (centrosomal protein 152) This gene encodes a protein that is thought to be involved with centrosome function. Mutations in this gene have been associated with primary microcephaly (MCPH4). Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2010]
CEP152 Gene-Disease associations (from GenCC):
  • microcephaly with or without short stature
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Seckel syndrome 5
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • microcephaly 9, primary, autosomal recessive
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • autosomal recessive primary microcephaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • Seckel syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 15-48791380-C-T is Benign according to our data. Variant chr15-48791380-C-T is described in ClinVar as Benign. ClinVar VariationId is 158274.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.453 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CEP152NM_001194998.2 linkc.833-4G>A splice_region_variant, intron_variant Intron 7 of 26 ENST00000380950.7 NP_001181927.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CEP152ENST00000380950.7 linkc.833-4G>A splice_region_variant, intron_variant Intron 7 of 26 1 NM_001194998.2 ENSP00000370337.2
CEP152ENST00000399334.7 linkc.833-4G>A splice_region_variant, intron_variant Intron 7 of 25 1 ENSP00000382271.3
CEP152ENST00000325747.9 linkc.554-4G>A splice_region_variant, intron_variant Intron 6 of 24 1 ENSP00000321000.5
CEP152ENST00000560322.5 linkn.833-4G>A splice_region_variant, intron_variant Intron 7 of 12 1 ENSP00000453440.1

Frequencies

GnomAD3 genomes
AF:
0.397
AC:
60237
AN:
151566
Hom.:
12474
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.310
Gnomad AMI
AF:
0.551
Gnomad AMR
AF:
0.407
Gnomad ASJ
AF:
0.505
Gnomad EAS
AF:
0.334
Gnomad SAS
AF:
0.369
Gnomad FIN
AF:
0.322
Gnomad MID
AF:
0.462
Gnomad NFE
AF:
0.457
Gnomad OTH
AF:
0.444
GnomAD2 exomes
AF:
0.399
AC:
98822
AN:
247492
AF XY:
0.408
show subpopulations
Gnomad AFR exome
AF:
0.305
Gnomad AMR exome
AF:
0.321
Gnomad ASJ exome
AF:
0.502
Gnomad EAS exome
AF:
0.346
Gnomad FIN exome
AF:
0.318
Gnomad NFE exome
AF:
0.451
Gnomad OTH exome
AF:
0.433
GnomAD4 exome
AF:
0.442
AC:
643661
AN:
1455398
Hom.:
145123
Cov.:
33
AF XY:
0.442
AC XY:
319984
AN XY:
724310
show subpopulations
African (AFR)
AF:
0.300
AC:
10037
AN:
33402
American (AMR)
AF:
0.330
AC:
14753
AN:
44682
Ashkenazi Jewish (ASJ)
AF:
0.491
AC:
12809
AN:
26086
East Asian (EAS)
AF:
0.333
AC:
13178
AN:
39590
South Asian (SAS)
AF:
0.397
AC:
34158
AN:
86088
European-Finnish (FIN)
AF:
0.327
AC:
16681
AN:
51066
Middle Eastern (MID)
AF:
0.478
AC:
2747
AN:
5750
European-Non Finnish (NFE)
AF:
0.463
AC:
512849
AN:
1108524
Other (OTH)
AF:
0.439
AC:
26449
AN:
60210
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.466
Heterozygous variant carriers
0
16039
32078
48117
64156
80195
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
15206
30412
45618
60824
76030
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.397
AC:
60248
AN:
151686
Hom.:
12474
Cov.:
31
AF XY:
0.390
AC XY:
28909
AN XY:
74100
show subpopulations
African (AFR)
AF:
0.310
AC:
12796
AN:
41322
American (AMR)
AF:
0.406
AC:
6198
AN:
15258
Ashkenazi Jewish (ASJ)
AF:
0.505
AC:
1751
AN:
3470
East Asian (EAS)
AF:
0.335
AC:
1727
AN:
5158
South Asian (SAS)
AF:
0.370
AC:
1767
AN:
4780
European-Finnish (FIN)
AF:
0.322
AC:
3382
AN:
10488
Middle Eastern (MID)
AF:
0.473
AC:
138
AN:
292
European-Non Finnish (NFE)
AF:
0.457
AC:
31062
AN:
67900
Other (OTH)
AF:
0.439
AC:
928
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1785
3571
5356
7142
8927
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
576
1152
1728
2304
2880
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.449
Hom.:
6272
Bravo
AF:
0.402
Asia WGS
AF:
0.289
AC:
1007
AN:
3476
EpiCase
AF:
0.472
EpiControl
AF:
0.487

ClinVar

Significance: Benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:5
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Feb 08, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:3
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Microcephaly 9, primary, autosomal recessive Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Seckel syndrome 5 Benign:1
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
9.4
DANN
Benign
0.44
PhyloP100
-0.14
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.000023
dbscSNV1_RF
Benign
0.012
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs58156069; hg19: chr15-49083577; COSMIC: COSV57857885; COSMIC: COSV57857885; API